Signal transducer and activator of transcription 3 (STAT3) is becoming part of the most prevalent studies in anti-cancer therapy, owing to its inhibition reported to trigger a variety of cell apoptosis in hematologica and solid cancers that show constitutive STAT3 activation (63). Here, STAT3 is linked to cancer.